Infolinx Extends Presence with Global Biopharmaceutical Company

Infolinx Extends Presence with Global Biopharmaceutical Company
Infolinx WEB Assists with FDA Regulations Compliance
Today, Infolinx announced the adoption of its industry leading physical records management application, Infolinx WEB, by a global biopharmaceutical corporation with their products marketed in over 50 countries worldwide and offices in over 25 countries. The application will be used in their Quality Assurance, Quality Control and Quality System Master and Validation departments to complement the collection of documented evidence necessary for to comply with all applicable FDA regulatory compliance.

"Having provided records management consultation and software services for nearly more than twenty years, Infolinx has considerable experience helping pharmaceutical providers implement strategic and scalable records management solutions, meeting today's stringent requirements." said Chip Benson, Director of New Business Development.

In the highly regulated and competitive pharmaceutical industry, corporate records management programs have become indispensable to the continued well-being of the organization. Seeking industry-recognized compliance, pharmaceutical companies are actively seeking pursuing records management software and services to assist them in their efforts.

Under these compliance requirements, a variety of corporate records, including product batch, history and intellectual property files as well as research notebooks and other physical records must now all now be governed by corporate policies implemented throughout their life cycle. Inherent in these policies is the mandatory ability to restrict, locate, track and audit access to all such records. Increasingly, the pharmaceutical industry is turning to companies like Infolinx to ensure regulatory compliance and establish programs reflecting best records management practices.

About Infolinx
Infolinx System Solutions is a leading provider of enterprise physical records management software, professional business services and information management consulting products to a broad range of commercial and government clients worldwide. Infolinx solutions and services manage critical business documents from point of creation through final disposition, offering customers reduced risk and improved operational efficiencies with a verifiable return on investment. Infolinx maintains clients within all major business segments and the public sector. Visit Infolinx System Solutions for additional information.

 

Suggested Articles

CureVac will spend the bulk of the proceeds on its COVID-19 vaccine, with the rest going to manufacturing, platform development and other programs.

WuXi names Dong to helm new vaccines CDMO; Paragon appoints Jimenez as capital makers lead; Levy joins Spark as CMO.

The phase 1 and 2 results suggest the vaccine may be safe, tolerable and capable of triggering production of antibodies against the coronavirus.